You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.
NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.
Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.
In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.
The US Centers for Disease Control and Prevention has identified a small group of breakthrough COVID-19 cases, the Wall Street Journal reports.
Vox and Nature discuss the importance of preparing for the next pandemic.
The New York Times reports that the US Department of Defense is to use genetic genealogy approaches to identify the remains of unknown soldiers.
In Nature this week: comparison of five circulating tumor DNA assays, resequencing analysis of lettuce gives insight into its domestication, and more.
According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.
A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.
In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.
The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.
CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.
According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.
In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.
President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.
Nature News writes that viral genomic surveillance in the US faces systemic issues.
A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.
In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.
NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.
Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.
Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.
In Science this week: review discusses advances in liquid biopsies, and more.
The Los Angeles Times reports that current SARS-CoV-2 vaccines may be effective against the viral variant first identified in California.
CNN reports that the B.1.1.7 variant of SARS-CoV-2 is now the most common one circulating in the US.